Trial intelligence / Profile preview

Low dose HCG in ICSI antagonist protocol

NCT01833858Phase 3Completed

Sponsor
Cairo University
Start
Aug 2013
Primary completion
Oct 2014
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 3 trial of human chorionic gonadotropin in infertility, sponsored by Cairo University. Started Aug 2013; status: completed.

02

Drugs

human chorionic gonadotropin
03

Conditions

infertility

Beyond the preview

Go deeper on NCT01833858.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01833858.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call